EHealthline.com, Inc. v. Pharmaniaga Berhad

CourtDistrict Court, E.D. California
DecidedSeptember 11, 2020
Docket2:18-cv-01069
StatusUnknown

This text of EHealthline.com, Inc. v. Pharmaniaga Berhad (EHealthline.com, Inc. v. Pharmaniaga Berhad) is published on Counsel Stack Legal Research, covering District Court, E.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
EHealthline.com, Inc. v. Pharmaniaga Berhad, (E.D. Cal. 2020).

Opinion

1 2 3 4 5 6 7 8 UNITED STATES DISTRICT COURT 9 FOR THE EASTERN DISTRICT OF CALIFORNIA 10 11 E*HEALTHLINE.COM, INC., a Delaware No. 2:18-cv-1069-MCE-EFB corporation, 12 Plaintiff, 13 FINDINGS AND RECOMMENDATIONS v. 14 PHARMANIAGA BERHAD, and 15 MODERN INDUSTRIAL INVESTMENT HOLDING GROUP COMPANY 16 LIMITED, 17 Defendants. 18 19 This case is before the court on plaintiff’s motion for default judgment against Modern 20 Industrial Investment Holding Group Company Limited (“Modern”).1 ECF No. 81. For the 21 reasons stated below, it is recommended the motion be denied for lack of subject matter 22 jurisdiction.2 23 ///// 24 /////

25 1 This case was referred to the undersigned pursuant to Eastern District of California 26 Local Rule 302(c)(19). See 28 U.S.C. § 636(b)(1).

27 2 The court determined that oral argument would not materially assist in the resolution of the motion. Accordingly, the matter was ordered submitted on the briefs, ECF No. 88. See E.D. 28 Cal. L.R. 230(g). 1 I. Background 2 Plaintiff E*Healthline (“EHL”) filed this action against defendants Pharmaniaga Berhad 3 (“Pharmaniaga”) and Modern, claiming defendants misappropriated trade secrets and confidential 4 information. ECF No. 1. Pharmaniaga, a Malaysian corporation, moved to dismiss the original 5 complaint for lack of subject matter jurisdiction. ECF No. 20. That motion was granted and the 6 complaint was dismissed with leave to amend. ECF No. 38. Additionally, after Modern, a 7 privately-owned company established under the laws of Saudi Arabia, failed to timely respond to 8 the complaint, plaintiff moved for entry of its default. ECF No. 34. That request was denied 9 because plaintiff failed to demonstrate that Modern had been properly served.3 ECF No. 39. 10 Thereafter, plaintiff renewed its request for entry of Modern’s default. ECF No. 42. It 11 also filed a first amended complaint (ECF No. 43), which drew another motion to dismiss for lack 12 of personal jurisdiction (ECF No. 46). Plaintiff’s renewed request for entry of default was 13 granted, and Modern’s default was entered on January 7, 2019. However, plaintiff again failed to 14 demonstrate that the court had personal jurisdiction over Pharmaniaga, and the claims in the first 15 amended complaint against that defendant were dismissed. Plaintiff was granted leave to amend 16 as a final opportunity do so. ECF No. 63. 17 Plaintiff subsequently filed its second amended complaint (ECF No. 64), which is the 18 operative complaint. That complaint alleges defendants misappropriated plaintiff’s confidential 19 information in violation of the Defendant Trade Secrets Act of 2016, 18 U.S.C. §§ 1936, et seq.; 20 Racketeer Influenced and Corrupt Organization Act, 18 U.S.C. §§ 1961, et seq.; and California 21 Misappropriation of Confidential Information Uniform Trade Secrets Act, Cal. Civ. Code 22 § 3426.1. ECF No. 64 at 51-58. 23 According to the second amended complaint, plaintiff previously entered into commission 24 agreements with two independent contractors who were to assist plaintiff in identifying business 25 opportunities. Id ¶¶ 52, 53. In February 2011, one of the independent contractors, Chris 26 Crockett, notified plaintiff of a pharmaceutical manufacturing opportunity in Saudi Arabia. Id. 27 3 The order also noted that the court was not “at all convinced that it would have 28 jurisdiction over Modern even if service has been properly effectuated.” ECF No. 39 at 1. 1 ¶ 54. Through Mr. Crocket, plaintiff arranged a telephonic conference with Modern to discuss 2 the potential pharmaceutical project. Id. ¶¶ 54-57. Plaintiff subsequently contacted Pharmaniaga 3 to inquire whether it would be interested in a joint venture in Saudi Arabia. Id. ¶¶ 62-63. Over 4 the next several months, the parties exchanged emails and conducted teleconferences to discuss 5 the possibility of establishing a pharmaceutical manufacturing plant in Saudi Arabia. Id. ¶¶ 64- 6 116, 122, 125-38. To facilitate the proposed venture, plaintiff and Modern entered into a non- 7 disclosure agreement in July 2011. Id. ¶¶ 26, 36. Thereafter, plaintiff disclosed to the defendants 8 confidential information and trade secrets. Id. ¶¶ 81-139. 9 On October 27, 2011, the parties met in Frankfurt, Germany, and entered in a 10 Memorandum of Collaboration (“MOC”), which included stringent confidentiality and non- 11 competition provisions. Id. ¶¶ 40-41, 140. The parties continued to communicate about the joint 12 venture through 2012 and early 2013. However, in May 2013, Pharmaniaga publicly announced 13 that it had entered into a joint venture with Modern to construct and operate a pharmaceutical 14 manufacturing plant in Saudi Arabia. Id. ¶¶ 193. Prior to this announcement, plaintiff was not 15 aware that Pharmaniaga and Modern had been working to exclude plaintiff from the project. Id. 16 II. Discussion 17 Plaintiff again confronts the fundamental and threshold barrier to proceeding on these 18 claims: whether this court has personal jurisdiction over Modern. ECF No. 81-1 at 5-7. Plaintiff 19 claims that the court may exercise specific jurisdiction over Modern because its actions were 20 directed towards the forum through its intentional misappropriation of trade secrets. Id. 21 A. Relevant Legal Standard 22 “A defendant’s default does not automatically entitle the plaintiff to a court-ordered 23 judgment.” PepsiCo, Inc. v. Cal. Sec. Cans, 238 F. Supp. 2d 1172, 1174 (C.D. Cal. 2002). In 24 deciding a motion for default judgment, a “district court has an affirmative duty to look into its 25 jurisdiction over both the subject matter and the parties.” In re Tuli, 172 F.3d 707, 712 (9th Cir. 26 1999). When, as here, the court evaluates personal jurisdiction without an evidentiary hearing, 27 the plaintiff’s burden is light: “the plaintiff need only make ‘a prima facie showing of 28 jurisdictional facts . . . .’” CollegeSource, Inc. v. AcademyOne, Inc., 653 F.3d 1066, 1073 (9th 1 Cir. 2011). The uncontroverted allegations in the complaint are taken as true, and factual disputes 2 are resolved in the plaintiff’s favor. Id. 3 California’s long-arm statute, California Civil Procedure Code section 410.10, authorizes 4 the court to exercise personal jurisdiction to the extent permitted by federal due process. Id. at 5 1074. For a court to exercise personal jurisdiction over a nonresident defendant consistent with 6 due process, that defendant must have “certain minimum contacts . . . such that the maintenance 7 of the suit does not offend ‘traditional notions of fair play and substantial justice.’” Calder v. 8 Jones, 465 U.S. 783, 788 (1984); CollegeSource, 653 F.3d at 1074. If the nonresident 9 defendant’s contacts with the state are not sufficiently continuous or systematic to give rise to 10 “general personal jurisdiction,” the defendant may still be subject to “specific personal 11 jurisdiction” on claims arising out of defendant’s contacts with the forum state. Burger King 12 Corp. v. Rudzewicz, 471 U.S. 462, 477-78 (1985); Haisten v. Grass Valley Med. Reimbursement 13 Fund, Ltd., 784 F.2d 1392, 1397 (9th Cir. 1986).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Burger King Corp. v. Rudzewicz
471 U.S. 462 (Supreme Court, 1985)
United States v. Bonds
608 F.3d 495 (Ninth Circuit, 2010)
United States v. Luongo
11 F.3d 7 (First Circuit, 1993)
CollegeSource, Inc. v. AcademyOne, Inc.
653 F.3d 1066 (Ninth Circuit, 2011)
Sher v. Johnson
911 F.2d 1357 (Ninth Circuit, 1990)
Pepsico, Inc. v. California Security Cans
238 F. Supp. 2d 1172 (C.D. California, 2002)
Burt v. Titlow
134 S. Ct. 10 (Supreme Court, 2013)
Walden v. Fiore
134 S. Ct. 1115 (Supreme Court, 2014)
Bernard Picot v. Dean Weston
780 F.3d 1206 (Ninth Circuit, 2015)
Axiom Foods, Inc. v. Acerchem International, Inc.
874 F.3d 1064 (Ninth Circuit, 2017)
Turner v. Duncan
158 F.3d 449 (Ninth Circuit, 1998)
Schwarzenegger v. Fred Martin Motor Co.
374 F.3d 797 (Ninth Circuit, 2004)
Roth v. Garcia Marquez
942 F.2d 617 (Ninth Circuit, 1991)

Cite This Page — Counsel Stack

Bluebook (online)
EHealthline.com, Inc. v. Pharmaniaga Berhad, Counsel Stack Legal Research, https://law.counselstack.com/opinion/ehealthlinecom-inc-v-pharmaniaga-berhad-caed-2020.